TM4SF5-mediated protein-protein networks and tumorigenic roles
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Transmembrane 4 L six family member 5 (TM4SF5), as amembrane glycoprotein with 4 transmembrane domains, issimilar to the tetraspanins in terms of membrane topology andplays important roles in tumorigenesis and tumor metastasis. Especially, TM4SF5 appears to form a massive protein-proteincomplex consisting of diverse membrane proteins and/orreceptors in addition to cytosolic signaling molecules toregulate their signaling activities during the pathologicalprocesses. TM4SF5 is shown to interact with integrins α2, α5,and β1, EGFR, IL6R, CD151, focal adhesion kinase (FAK), andc-Src. This review focuses on the significance of theinteractions with regards to TM4SF5-positive tumorigenesisand metastasis.
Abstract
Transmembrane 4 L six family member 5 (TM4SF5), as amembrane glycoprotein with 4 transmembrane domains, issimilar to the tetraspanins in terms of membrane topology andplays important roles in tumorigenesis and tumor metastasis. Especially, TM4SF5 appears to form a massive protein-proteincomplex consisting of diverse membrane proteins and/orreceptors in addition to cytosolic signaling molecules toregulate their signaling activities during the pathologicalprocesses. TM4SF5 is shown to interact with integrins α2, α5,and β1, EGFR, IL6R, CD151, focal adhesion kinase (FAK), andc-Src. This review focuses on the significance of theinteractions with regards to TM4SF5-positive tumorigenesisand metastasis.
참고문헌 (28)
- Veenbergen, S., "Tetraspanins in the immune response against cancer", Immunol. Lett, 138, pp.129~136 (2011)
- Detchokul, S., "Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies", Br. J. Pharmacol (2013)[DOI]
- Lee, S. A., "Modulation of signaling between TM4SF5 and integrins in tumor microenvironment", Front. Biosci, 16, pp.1752~1758 (2011)
- Hemler, M. E., "Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain", Annu. Rev. Cell Dev. Biol, 19, pp.397~422 (2003)
- Hemler, M. E., "Tetraspanin functions and associated microdomains", Nat. Rev. Mol. Cell Biol, 6, pp.801~811 (2005)
- Yanez-Mo, M., "Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes", Trends. Cell Biol, 19, pp.434~446 (2009)
- Lee, S. A., "Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial- mesenchymal transition in human hepatocarcinoma", J. Clin. Invest, 118, pp.1354~1366 (2008)
- Muller-Pillasch, F., "Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer", Gene, 208, pp.25~30 (1998)
- Berditchevski, F., "Tetraspanins as regulators of protein trafficking", Traffic, 8, pp.89~96 (2007)
- Charrin, S., "Lateral organization of membrane proteins: tetraspanins spin their web", Biochem. J, 420, pp.133~154 (2009)
- Choi, S., "Cooperation between integrin α5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity", Blood, 113, pp.1845~1855 (2009)
- Lee, S. A., "The extracellular loop 2 of TM4SF5 inhibits integrin α2 on hepatocytes under collagen type I environment", Carcinogenesis, 30, pp.1872~1879 (2009)
- Lee, S. A., "Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative", Hepatology, 49, pp.1316~1325 (2009)
- Choi, Y. J., "TM4SF5 suppression disturbs integrin α5-related signaling and muscle development in zebrafish", Biochem. J, 462, pp.89~101 (2014)
- Lee, S. Y., "Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin α2 are regulated by serum treatment", Exp. Cell Res, 312, pp.2983~2999 (2006)
- Lee, M. S., "Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition", Biochim. Biophys. Acta, 1823, pp.514~523 (2012)
- Kang, M., "Cross-talk between TGFb1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition", Biochem. J, 443, pp.691~700 (2012)
- Kang, M., "Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl4-treated mice", FEBS. J, 279, pp.625~635 (2012)
- Sangiovanni, A., "Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance", Gastroenterology, 126, pp.1005~1014 (2004)
- Severi, T., "Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets", Acta. Pharmacol. Sin, 31, pp.1409~1420 (2010)
- Ghosh, A. K., "Molecular basis of organ fibrosis: potential therapeutic approaches", Exp. Biol. Med (Maywood), 238, pp.461~481 (2013)
- Meindl-Beinker, N. M., "TGF-beta signaling in onset and progression of hepatocellular carcinoma", Dig. Dis, 30, pp.514~523 (2012)
- Mantovani, A., "The chemokine system in cancer biology and therapy", Cytokine. Growth. Factor. Rev, 21, pp.27~39 (2010)
- Ryu, J., "Cross-talk between the TM4SF5", FAK and the IL6, Mol. Cell Biol, pp.2014, 34[DOI]
- Kang, M., "Correlations between Transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities", PLoS ONE, 9, pp.e102817~ (2014)[DOI]
- Lietha, D., "Structural basis for the autoinhibition of focal adhesion kinase", Cell, 129, pp.1177~1187 (2007)
- Jung, O., "Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells", J. Cell Sci, 125, pp.5960~5973 (2012)
- Jung, O., "The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation", Biochim. Biophys. Acta, 1833, pp.629~642 (2013)
